Your browser doesn't support javascript.
loading
Electronic alerts to improve management of heparin-induced thrombocytopenia.
Zon, Rebecca L; Sylvester, Katelyn W; Rubins, David; Grandoni, Jessica; Kelly, Julie; Timilsina, Shreya; Akladious, Mark; Patel, Rajesh; Connors, Jean M.
Afiliación
  • Zon RL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Sylvester KW; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Rubins D; Harvard Medical School, Boston, Massachusetts, USA.
  • Grandoni J; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Kelly J; Harvard Medical School, Boston, Massachusetts, USA.
  • Timilsina S; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Akladious M; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Patel R; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Connors JM; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Res Pract Thromb Haemost ; 8(4): 102423, 2024 May.
Article en En | MEDLINE | ID: mdl-38953054
ABSTRACT

Background:

Heparin-induced thrombocytopenia (HIT) is a difficult clinicopathologic diagnosis to make and to treat. Delays in identification and appropriate treatment can lead to increased morbidity and mortality.

Objectives:

To use electronic health alert interventions to improve provider diagnosis and management of heparin-induced thrombocytopenia through guideline-based, accurate care delivery.

Methods:

This quality improvement initiative developed 3 electronic health record-based interventions at our 750-bed academic medical center to improve the initial management of suspected HIT between 2018 and 2021 1. an interruptive alert to recommend discontinuation of active heparin products when signing a heparin-platelet factor 4 test (PF4) order, 2. integrated 4T score calculation in the heparin-PF4 test order, and 3. interruptive alert suggesting not to order heparin-PF4 tests when the 4T score is <4. Changes in practice were assessed over defined time periods pre and post each intervention.

Results:

Intervention 1 resulted in heparin discontinuation in more patients, with 65% (191 heparin orders/293 heparin-PF4 enzyme-linked immunosorbent assay tests) of cases continuing heparin prealert and only 54% (127 heparin orders/235 heparin-PF4 enzyme-linked immunosorbent assay tests) postinterruptive alert (95% CI 2.3-19.9; P = .015). Intervention 2 increased appropriate heparin-PF4 test ordering from 40.4% (110/272) preintervention to 79.1% (246/311) (95% CI 30.9-46.4; P < .00001) postintervention, with inappropriate PF4 ordering defined as testing when 4T score was <4. Intervention 3 did not lead to reduction in heparin-PF4 testing in the control group (96 inappropriate orders/402 total orders, 24%) compared to the randomized alert group (56 inappropriate orders/298 total orders; 19%) (95% CI -1.2 to 11.5; P = .13).

Conclusion:

Implementation of unique electronic health record interventions, including both diagnostic and management interventions, led to improved guideline-based, accurate care delivery with 4T score calculation and cessation of heparin for patients with suspected HIT.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos